The DOI matches its Crossref record.
How artificial intelligence is changing drug discovery
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“AI is, for example, the major driver behind the current trend toward personalized medicine, with treatments being tailored to each patient's specific biological profile (Fleming, 2018;Lichfield, 2018).”
From Artificial Intelligence and Management: The Automation–Augmentation Paradox (2021) · cites this paper as Fleming, 2018
Experimental — accuracy not yet measuredIn the citing paper
“Many more examples are available [3,32,33,34,35,36,37], showing that AI-based methods can accelerate the drug discovery process and enable the development of more effective medications.”
From The role of AI in drug discovery: challenges, opportunities, and strategies (2023) · cites this paper as [37]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Sorted by citations
Artificial Intelligence and Management: The Automation–Augmentation Paradox
Raisch, S., & Krakowski, S. (2021) · Academy of Management Review · doi:10.5465/amr.2018.0072 · Cited by 2,755
Artificial intelligence in drug discovery and development
Paul, D., Sanap, G., Shenoy, S., Kalyane, D., Kalia, K., & Tekade, R. K. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2020.10.010 · Cited by 1,695
“Even then, nine out of ten therapeutic molecules fail Phase II clinical trials and regulatory approval [31,32].”
BackgroundMikalef, P., & Gupta, M. (2021) · Information & Management · doi:10.1016/j.im.2021.103434 · Cited by 1,700
Artificial intelligence to deep learning: machine intelligence approach for drug discovery
Gupta, R., Srivastava, D., Sahu, M., Tiwari, S., Ambasta, R. K., & Kumar, P. (2021) · Molecular Diversity · doi:10.1007/s11030-021-10217-3 · Cited by 1,473
Deep learning: new computational modelling techniques for genomics
Eraslan, G., Avsec, Ž., Gagneur, J., & Theis, F. J. (2019) · Nature Reviews Genetics · doi:10.1038/s41576-019-0122-6 · Cited by 1,288
Metadata
- Authors
- Fleming, N.
- Corresponding author
- Fleming, Nic
- Venue
- Nature
- Published
- 2018-05-30
- Volume
- 557
- Issue
- 7707
- Pages
- S55-S57
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2806834952
- Cited by
- 546
- References
- 0
- Citations by year
- 2026: 41 · 2025: 49 · 2024: 81 · 2023: 95 · 2022: 97 · 2021: 81 · 2020: 56 · 2019: 38 · 2018: 7
- FWCI
- 34.22
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Physical Sciences › Materials Science › Materials Chemistry › Machine Learning in Materials Science
- Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
- Keywords
- artificial intelligence, drug discovery, machine learning, pharmaceuticals, computer-aided drug design
- MeSH terms
- Machine Learning, Algorithms, Amyotrophic Lateral Sclerosis, Animals, Artificial Intelligence, Automation, Drug Industry, Humans, Neoplasms, Pattern Recognition, Automated, Robotics, Efficiency, Organizational, Mice, Drug Discovery, Precision Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
